Cart
sales@molnova.com
4-Chloro-2-(trifluoroacetyl)aniline hydrochloride
CAS No. 173676-59-0
4-Chloro-2-(trifluoroacetyl)aniline hydrochloride( —— )
Catalog No. M20868 CAS No. 173676-59-0
4-Chloro-2-(trifluoroacetyl)aniline hydrochloride is an inhibitor of HIV-1 RT (HIV reverse transcriptase) .
4-Chloro-2-(trifluoroacetyl)aniline hydrochloride is an inhibitor of HIV-1 RT (HIV reverse transcriptase) .
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 46 | In Stock |
|
| 25MG | 83 | In Stock |
|
| 50MG | 125 | In Stock |
|
| 100MG | 196 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name4-Chloro-2-(trifluoroacetyl)aniline hydrochloride
-
NoteResearch use only, not for human use.
-
Brief Description4-Chloro-2-(trifluoroacetyl)aniline hydrochloride is an inhibitor of HIV-1 RT (HIV reverse transcriptase) .
-
Description4-Chloro-2-(trifluoroacetyl)aniline hydrochloride is an inhibitor of HIV-1 RT (HIV reverse transcriptase) .
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMicrobiology/Virology
-
TargetHIV
-
RecptorHIV-1 RT
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number173676-59-0
-
Formula Weight260.04
-
Molecular FormulaC8H6Cl2F3NO
-
Purity>98% (HPLC)
-
SolubilityDMSO:52mg/mL(199.97mM)
-
SMILESCl.Nc1ccc(Cl)cc1C(=O)C(F)(F)F
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
WAY-383487
WAY-383487 is one of the Tat peptide derivatives and inhibits HIV-1 long terminal repeat-activated transcription.
-
DAPTA
DAPTA is a synthetic peptide, functions as a viral entry inhibitor by targeting selectively CCR5, and shows potent anti-HIV activities. DAPTA potently inhibits specific CD4-dependent binding of gp120 Bal (IC50 = 0.06 nM) and CM235 (IC50 = 0.32 nM) to CCR5.
-
SCH 350581
A specific small molecule inhibitor of CCR5, inhibits HIV-1 entry.
